Table 2.
Weighted associations between NHR (continuous and quartile-based) and psoriasis risk.
OR (95% CI) | |||
---|---|---|---|
Model 1 | Model 2 | Model 3 | |
(N= 21,723) | (N= 21,723) | (N= 21,723) | |
NHR | 1.09 (1.08, 1.10) <0.001 | 1.09 (1.08, 1.10) <0.001 | 1.04 (1.02, 1.05) <0.001 |
Stratified by NHR quartiles | |||
Q1 | Reference | Reference | Reference |
Q2 | 1.08 (1.02, 1.15) 0.009 | 1.07 (1.01, 1.14) 0.017 | 0.99 (0.93, 1.05)0.710 |
Q3 | 1.31 (1.24, 1.39) <0.001 | 1.31 (1.25, 1.40) <0.001 | 1.14 (1.07, 1.21) <0.001 |
Q4 | 1.52 (1.44, 1.60) <0.001 | 1.56 (1.47, 1.65) <0.001 | 1.24 (1.17, 1.32) <0.001 |
P for trend | <0.001 | <0.001 | <0.001 |
Model 1: adjusted for none.
Model 2: adjusted for age (years), sex, and race.
Model 3: adjusted for age (years), sex, race, PIR, BMI, cigarette use, hypertension, education, diabetes, cancer, marital status, heart attack and alcohol use.
BMI, body mass index; PIR, family income–poverty ratio; OR, odds ratio; NHR, neutrophil-to-high-density lipoprotein cholesterol ratio; CI, confidence interval.